NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI)
Who is NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI)?
The Nucleic Acid Therapeutics Initiative (NATi) is a national platform that aims to build Singapore into a regional hub for nucleic acid therapeutics (NAT) research, clinical translation, and commercialisation. NATi harnesses the potential of nucleic acids to treat diseases using RNA molecules. Thi...See more
Industry & Specialities
Others
Countries of Operation
Singapore
Headquarters:
Singapore
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2023 (3 years)
Address:
NANOS, LEVEL 5, 31 BIOPOLIS WAY, SINGAPORE 138669; SINGAPORE, SG
Employees by Department
Key Decision Makers
Vira Bitko
Head of Vaccines and Immunology
Emilie Soh
Program Manager
Nani Djunaidi
Project Manager
Cher Hui Goey Meng
Scientific Portfolio Manager
Employees by Seniority
C-level
0employees
Senior
5employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI) been operating for?
- What is the funding status of NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI)?
- Where is NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI)'s headquarter?
- What NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI)'s spending power?
- Does NUCLEIC ACID THERAPEUTICS INITIATIVE (NATI) have a presence in the domain it operates in?